US Stock MarketDetailed Quotes

Syra Health (SYRA)

Watchlist
  • 0.0800
  • -0.0020-2.44%
15min DelayClose Jan 15 14:10 ET
955.13KMarket Cap-1.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Syra Health (SYRA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
40.89%-244.31K
95.18%-72.48K
119.76%158.23K
-6.27%-2.93M
87.78%-214.72K
-11.93%-413.3K
-155.79%-1.5M
-1,676.99%-800.75K
-22.95%-2.76M
-43.85%-1.76M
Net income from continuing operations
45.90%-225.9K
95.43%-63.6K
67.36%-472.27K
-27.94%-3.76M
49.32%-504.4K
-17.82%-417.54K
-73.18%-1.39M
-84.13%-1.45M
-38.72%-2.94M
-62.46%-995.28K
Depreciation and amortization
-78.87%5.4K
-65.59%5.98K
-45.82%6.8K
28.64%62.74K
-41.11%7.28K
106.69%25.54K
41.33%17.37K
6.65%12.55K
228.45%48.77K
22.87%12.36K
Other non cash items
--0
--0
-94.85%2.59K
32.86%160.88K
-25.53%23.03K
21.03%36.9K
68.71%50.7K
69.62%50.25K
-80.46%121.09K
-6.74%30.93K
Change In working capital
22.81%-44.93K
81.59%-35.98K
3.30%588.17K
2,422.28%543.79K
127.67%228.05K
1.03%-58.2K
-220.93%-195.43K
-18.44%569.37K
96.93%-23.42K
-26.09%-824.29K
-Change in receivables
7.09%-39.89K
534.30%59.5K
-193.50%-265.03K
490.72%430.42K
182.61%203.62K
93.31%-42.94K
76.10%-13.7K
-66.07%283.44K
88.29%-110.16K
57.86%-246.49K
-Change in payables and accrued expense
98.72%-1.94K
149.81%144.92K
-32.47%204.82K
-6,569.71%-305.63K
69.75%-166.2K
-134.70%-151.79K
-339.58%-290.93K
6,510.82%303.3K
-99.00%4.72K
-1,179.45%-549.37K
-Change in other current assets
-147.98%-65.5K
-11.49%124.82K
3,826.51%310.19K
142.18%491.88K
43.22%206.43K
296.13%136.53K
10.58%141.03K
107.67%7.9K
201.15%203.11K
259.34%144.13K
-Change in other current liabilities
--187.41K
-2.46%-32.61K
-679.07%-244.42K
26.09%-89.5K
14.96%-26.3K
--0
-5.90%-31.83K
-5.90%-31.37K
-26.71%-121.09K
-5.91%-30.93K
-Change in other working capital
---125K
---332.6K
9,438.34%582.6K
--16.61K
--10.5K
--0
--0
--6.11K
----
----
Cash from discontinued investing activities
Operating cash flow
40.89%-244.31K
95.18%-72.48K
119.76%158.23K
-6.27%-2.93M
87.78%-214.72K
-11.93%-413.3K
-155.79%-1.5M
-1,676.99%-800.75K
-22.95%-2.76M
-43.85%-1.76M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
27.15%-11.11K
0
0
1.79%-5.49K
41.83%-5.62K
87.42%-15.25K
0
Net PPE purchase and sale
--0
--0
--0
27.15%-11.11K
--0
--0
1.79%-5.49K
41.83%-5.62K
87.42%-15.25K
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
27.15%-11.11K
--0
--0
1.79%-5.49K
41.83%-5.62K
87.42%-15.25K
--0
Financing cash flow
Cash flow from continuing financing activities
-105.61%-85.07K
16.81%-112.18K
-108.25%-63.05K
-65.98%2.06M
-101.74%-87.33K
332.24%1.52M
-504.57%-134.85K
17.98%764.25K
166.72%6.05M
734.96%5.02M
Net issuance payments of debt
17.10%-85.07K
16.81%-112.18K
9.35%-77.85K
-179.17%-410.68K
82.02%-87.33K
---102.61K
-166.90%-134.85K
-110.69%-85.88K
-29.56%518.76K
-164.73%-485.85K
Net common stock issuance
----
----
----
-53.69%2.47M
--0
----
----
----
129.59%5.33M
--5.33M
Proceeds from stock option exercised by employees
--0
--0
-98.26%14.8K
----
----
--1.62M
--0
--850.13K
----
----
Net other financing activities
----
----
----
----
----
----
----
----
125.31%200.01K
215.55%172.67K
Cash from discontinued financing activities
Financing cash flow
-105.61%-85.07K
16.81%-112.18K
-108.25%-63.05K
-65.98%2.06M
-101.74%-87.33K
332.24%1.52M
-504.57%-134.85K
17.98%764.25K
166.72%6.05M
734.96%5.02M
Net cash flow
Beginning cash position
44.63%2.31M
-23.08%2.49M
-26.97%2.4M
97,988.37%3.28M
14,877.56%2.7M
4,274.20%1.59M
442.91%3.24M
97,988.37%3.28M
-96.66%3.34K
-97.31%18.01K
Current changes in cash
-129.86%-329.38K
88.76%-184.66K
325.98%95.18K
-127.00%-884.67K
-109.26%-302.05K
6,082.47%1.1M
-193.52%-1.64M
-107.10%-42.12K
3,489.67%3.28M
590.40%3.26M
End cash Position
-26.73%1.98M
44.63%2.31M
-23.08%2.49M
-26.97%2.4M
-26.97%2.4M
14,877.56%2.7M
4,274.20%1.59M
442.91%3.24M
97,988.37%3.28M
97,988.37%3.28M
Free cash flow
40.89%-244.31K
95.20%-72.48K
119.62%158.23K
-6.09%-2.94M
87.78%-214.72K
-11.93%-413.3K
-154.30%-1.51M
-1,373.59%-806.36K
-17.29%-2.77M
-38.75%-1.76M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 40.89%-244.31K95.18%-72.48K119.76%158.23K-6.27%-2.93M87.78%-214.72K-11.93%-413.3K-155.79%-1.5M-1,676.99%-800.75K-22.95%-2.76M-43.85%-1.76M
Net income from continuing operations 45.90%-225.9K95.43%-63.6K67.36%-472.27K-27.94%-3.76M49.32%-504.4K-17.82%-417.54K-73.18%-1.39M-84.13%-1.45M-38.72%-2.94M-62.46%-995.28K
Depreciation and amortization -78.87%5.4K-65.59%5.98K-45.82%6.8K28.64%62.74K-41.11%7.28K106.69%25.54K41.33%17.37K6.65%12.55K228.45%48.77K22.87%12.36K
Other non cash items --0--0-94.85%2.59K32.86%160.88K-25.53%23.03K21.03%36.9K68.71%50.7K69.62%50.25K-80.46%121.09K-6.74%30.93K
Change In working capital 22.81%-44.93K81.59%-35.98K3.30%588.17K2,422.28%543.79K127.67%228.05K1.03%-58.2K-220.93%-195.43K-18.44%569.37K96.93%-23.42K-26.09%-824.29K
-Change in receivables 7.09%-39.89K534.30%59.5K-193.50%-265.03K490.72%430.42K182.61%203.62K93.31%-42.94K76.10%-13.7K-66.07%283.44K88.29%-110.16K57.86%-246.49K
-Change in payables and accrued expense 98.72%-1.94K149.81%144.92K-32.47%204.82K-6,569.71%-305.63K69.75%-166.2K-134.70%-151.79K-339.58%-290.93K6,510.82%303.3K-99.00%4.72K-1,179.45%-549.37K
-Change in other current assets -147.98%-65.5K-11.49%124.82K3,826.51%310.19K142.18%491.88K43.22%206.43K296.13%136.53K10.58%141.03K107.67%7.9K201.15%203.11K259.34%144.13K
-Change in other current liabilities --187.41K-2.46%-32.61K-679.07%-244.42K26.09%-89.5K14.96%-26.3K--0-5.90%-31.83K-5.90%-31.37K-26.71%-121.09K-5.91%-30.93K
-Change in other working capital ---125K---332.6K9,438.34%582.6K--16.61K--10.5K--0--0--6.11K--------
Cash from discontinued investing activities
Operating cash flow 40.89%-244.31K95.18%-72.48K119.76%158.23K-6.27%-2.93M87.78%-214.72K-11.93%-413.3K-155.79%-1.5M-1,676.99%-800.75K-22.95%-2.76M-43.85%-1.76M
Investing cash flow
Cash flow from continuing investing activities 00027.15%-11.11K001.79%-5.49K41.83%-5.62K87.42%-15.25K0
Net PPE purchase and sale --0--0--027.15%-11.11K--0--01.79%-5.49K41.83%-5.62K87.42%-15.25K--0
Cash from discontinued investing activities
Investing cash flow --0--0--027.15%-11.11K--0--01.79%-5.49K41.83%-5.62K87.42%-15.25K--0
Financing cash flow
Cash flow from continuing financing activities -105.61%-85.07K16.81%-112.18K-108.25%-63.05K-65.98%2.06M-101.74%-87.33K332.24%1.52M-504.57%-134.85K17.98%764.25K166.72%6.05M734.96%5.02M
Net issuance payments of debt 17.10%-85.07K16.81%-112.18K9.35%-77.85K-179.17%-410.68K82.02%-87.33K---102.61K-166.90%-134.85K-110.69%-85.88K-29.56%518.76K-164.73%-485.85K
Net common stock issuance -------------53.69%2.47M--0------------129.59%5.33M--5.33M
Proceeds from stock option exercised by employees --0--0-98.26%14.8K----------1.62M--0--850.13K--------
Net other financing activities --------------------------------125.31%200.01K215.55%172.67K
Cash from discontinued financing activities
Financing cash flow -105.61%-85.07K16.81%-112.18K-108.25%-63.05K-65.98%2.06M-101.74%-87.33K332.24%1.52M-504.57%-134.85K17.98%764.25K166.72%6.05M734.96%5.02M
Net cash flow
Beginning cash position 44.63%2.31M-23.08%2.49M-26.97%2.4M97,988.37%3.28M14,877.56%2.7M4,274.20%1.59M442.91%3.24M97,988.37%3.28M-96.66%3.34K-97.31%18.01K
Current changes in cash -129.86%-329.38K88.76%-184.66K325.98%95.18K-127.00%-884.67K-109.26%-302.05K6,082.47%1.1M-193.52%-1.64M-107.10%-42.12K3,489.67%3.28M590.40%3.26M
End cash Position -26.73%1.98M44.63%2.31M-23.08%2.49M-26.97%2.4M-26.97%2.4M14,877.56%2.7M4,274.20%1.59M442.91%3.24M97,988.37%3.28M97,988.37%3.28M
Free cash flow 40.89%-244.31K95.20%-72.48K119.62%158.23K-6.09%-2.94M87.78%-214.72K-11.93%-413.3K-154.30%-1.51M-1,373.59%-806.36K-17.29%-2.77M-38.75%-1.76M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -